Open-access Determining women's awareness levels of gynecological cancer and their perceptions of breast cancer fatalism

SUMMARY

OBJECTIVE:  This study was conducted to determine women's awareness levels regarding gynecological cancers and their fatalistic perceptions regarding breast cancer.

METHODS:  This was a descriptive study conducted in a Family Health Centre District between October 2023 and August 2024. The study sample consisted of 333 women. A personal information form, Gynecological Cancer Awareness Scale, and breast cancer fatalism scale were used to collect data.

RESULTS:  The mean total score on the Gynecological Cancer Awareness Scale for the women participating in the study was 146.02±21.70, and the mean total score on the Breast Cancer Fatalism Scale was 7.40±2.61. Educational status, social security, obtaining information from healthcare professionals about gynecological cancers, and previous gynecological examination status of the participants explain 18.7% of the variance in the Gynecological Cancer Awareness Scale total score average. Additionally, age and educational status explain 13.6% of the variance in the Breast Cancer Fatalism Scale total score average.

CONCLUSION:  As a result, it can be said that women's awareness levels about gynecological cancers and their perception of breast cancer fatalism are above average. Therefore, education should be provided to increase awareness levels of gynecological cancers and reduce perceptions of breast cancer fatalism.

KEYWORDS:
Gynecological; Breast; Cancer; Awareness; Nursing

INTRODUCTION

Gynecological cancers, defined as malignant diseases of the female reproductive organs, are one of the leading causes of morbidity and mortality in women after breast cancer1,2. Gynecological cancers account for 7.24% of all cancer cases3. It is estimated that nearly one-fifth of all cancers occurring in women are gynecological cancers4. According to Global Cancer Statistics 2022, 6.17% of the 240,013 people newly diagnosed with cancer in our country were diagnosed with gynecological cancer. Of those diagnosed with gynecological cancer, 4.45% died5. Awareness among women of the factors that may contribute to gynecological cancers, along with participation in early diagnosis and screening, reduces the risk of death and illness caused by cancer6. Awareness levels among women are crucial in preventing gynecological cancers7. There are only a limited number of studies examining women's awareness levels regarding gynecological cancers2,8, and these studies indicate that women's awareness levels are not high.

Although there are many factors affecting women's awareness, one of the important ones is fatalism. Individuals with fatalistic beliefs may think that there is no relationship between cancers and lifestyle and that early diagnosis and screening programs serve no purpose other than diagnosing the disease. This mindset may also lead to less use of early diagnosis services9.

Breast cancer is one of the cancers with a very high incidence in women. The fatalistic attitude toward breast cancer plays a very important role in the early diagnosis and treatment of breast cancer in women10. Individuals who adopt a fatalistic approach may oppose early diagnosis and screening programmes11. The literature reports that breast cancer fatalism has a negative impact on early diagnosis and screening behaviours12. The literature includes studies with low13 and high levels of breast cancer fatalism perception14.

In conclusion, it is evident that awareness levels and fatalistic perceptions play a significant role in the early detection of cancers observed in women. However, the limited number of studies on awareness levels regarding gynecological cancers highlights the need for further research in this area. The literature emphasizes the importance of determining the current situation in order to increase women's awareness levels regarding gynecological cancers. Furthermore, it is thought that women's awareness levels regarding gynecological cancers influence their fatalistic perceptions of breast cancer.

This study was conducted to determine women's awareness levels regarding gynecological cancers and their fatalistic perceptions regarding breast cancer.

Research questions

What are women's levels of gynecological cancer awareness and breast cancer fatalism perceptions?

What factors influence women's awareness of gynecological cancer and their perception of breast cancer fatalism?

METHODS

This descriptive study was conducted in the a Family Health Centre Region between October 2023 and August 2024.

In calculating the sample size of the research, the sample calculation method with a known population was used. The population size was taken as 2,497 women between the ages of 30–65, affiliated with a family health center; 95% confidence level (Z=1.96), 5% margin of error (d=0.05), and expected prevalence value p=0.50 were accepted. The minimum number of samples was found to be 333. Women who were not diagnosed with gynecological cancer and/or breast cancer and who had not had a hysterectomy were included in the study. During the sample selection process, the addresses of women who met the inclusion criteria were listed first. The addresses to be visited were then selected randomly using a table. The women were visited at their homes, the purpose of the study was explained to them, and they were given data collection forms. All of the women selected for the sample agreed to participate in the study.

There were no refusals. The data were collected by the researcher visiting the women in their homes and conducting face-to-face interviews lasting 15–20 min. The introductory information form, Gynecological Cancer Awareness Scale (GCAS), and Breast Cancer Fatalism Scale (BCFS) were used to collect the study data.

The Information Form was developed by researchers through a literature review2,8,15,16.

Gynecological Cancer Awareness Scale (GCAS) consists of 41 items and was developed by Dal and Ertem to determine the level of awareness of gynecological cancers among women aged 20–65 years16. The GCAS has four subscales (Awareness of Early Diagnosis and Information on Cancers, Awareness of Gynecological Cancer Risks, Awareness of Prevention of Gynecological Cancers, and Awareness of Routine Check-ups and Perception of Serious Illness in Gynecological Cancers). The Cronbach's alpha value of the scale is 0.944. The score obtained from the scale ranges from a minimum of 41 to a maximum of 205. There is a direct correlation between the scale score and the level of awareness16. In our study, the Cronbach's alpha value of the GCAS is 0.91.

Breast Cancer Fatalism Scale (BCFS) is a 15-item scale developed by Powe and revised by Mayo et al to 11 questions17,18. Its validity and reliability were established in Turkey by Ersin et al. The scale consists of 11 items, with a "Yes" response scoring 1 point and a "No" response scoring 0 points, resulting in a total score ranging from a minimum of 0 to a maximum of 11. Higher scores on the scale indicate greater fatalism10. In our study, the Cronbach's alpha value of the scale was 0.87.

Statistical analysis of data: Data analysis was performed using the SPSS 26.0 software package. The significance level was set at p<0.05. Descriptive statistics including frequency, percentage, and mean were used in the analysis of data. Additionally, t-tests for independent groups, Kruskal-Wallis analysis, Pearson correlation analysis, simple linear regression, and multiple linear regression analysis were performed. Skewness and kurtosis coefficients were considered in assessing the suitability of the normal distribution. Skewness and kurtosis coefficients were expected to be in the range of −1 to +119.

Ethical principles of the research: Permission was obtained from the Health Directorate (dated 08/12/2023 and numbered E-49781372-799-231234173) and the a University Clinical Research Ethics Committee (dated 13.11.2023 and numbered 2023/21/39) to conduct the research. Informed voluntary consent was obtained from the participants. The study was conducted in accordance with the Helsinki Declaration and the country's ethical standards.

RESULTS

The study found that 77.2% of women were aged between 30 and 49, 89.8% of women were married, 53.5% of women were illiterate, 51.4% of women had a poor income, 91% of women were unemployed, and 71.8% of women had no social security (Table 1).

Table 1
Distribution of women's sociodemographic characteristics.

About 14.7% of participants stated that they had a gynecological condition, while 32.4% of participants stated that they had not undergone a gynecological examination. The most frequently cited reasons for not having a gynecological examination were not feeling the need for one (50%), feeling embarrassed about having one (44.7%), and fear of the examination (38.6%). About 74.5% of women stated that they had heard of gynecological cancers, and 69.5% of women stated that they had heard about gynecological cancers from healthcare personnel. In addition, 4.5% of women stated that there was a history of gynecological cancer in their family, and 7.2% of women stated that they knew the symptoms of gynecological cancer.

A significant difference was found in the GCAS total score average among the women participating in the study according to their educational status (KW=10.079, p=0.018), income status (KW=6.966, p=0.031), and social security status (t=3.417, p=0.001). Furthermore, a significant difference was found in the mean total BCFS score according to the women's age (t=-4.934, p=0.000), educational status (KW=35.857, p=0.000), income status (KW=7.653, p=0.022), and social security status (t=2.686, p=0.007).

The mean total GCAS score for women was 146.02±21.70, and the mean total BCFS score was 7.40±2.61. GCAS Early Diagnosis and Information Awareness in Gynecological Cancers sub-dimension was 15.92±2.92, Gynecological Cancer Risks Awareness sub-dimension was 28.4±4.43, Gynecological Cancers Prevention Awareness sub-dimension was 15.51±3.63, and Routine Control and Serious Disease Perception in Gynecological Cancers sub-dimension was 86.85±18.37.

A very weak, negative, statistically significant correlation was found between participants’ GCAS scores and their BCFS scores (r=-.222, p=0.000) (Table 2).

Table 2
Correlation of mean scores of the Gynecological Cancers Awareness Scale and its subdimensions, and the Breast Cancer Fatalism Scale.

Educational status, social security, obtaining information from healthcare professionals about gynecological cancers, and previous gynecological examination status of the participants explain 18.7% of the variance in the GCAS total score average. Additionally, age and educational status explain 13.6% of the variance in the BCFS total score average (Table 3).

Table 3
Multiple lineage regression analysis between certain characteristics of women and their awareness of gynecological cancers and perceptions regarding fatalism in breast cancer.

DISCUSSION

The study found that the mean GCAS total score for women was 146.02±21.70. In the literature, GCAS total scores for women range from 148±25.71 to 160.31±22.4216,20,21. Considering that the highest possible average score on the scale is 205, it can be said that the level of awareness of gynecological cancers among women in this study is above average. In this study, the mean total score for gynecological cancer awareness among women was found to be 7.40±2.61. In one study in the literature, the mean total score for gynecological cancer awareness was 4.69±2.6721 and 6.00±3.5115 as stated. In this study, women's above-average fatalistic beliefs may be a hindering factor in implementing health behaviors.

Our study found that women's educational status affects the GCAS total score average. Previous studies also support this finding8,20, and it is noted that awareness of cervical cancer increases as the level of education rises21-23. Considering that education is considered important in raising awareness, this study shows that education explains only a small fraction of awareness. Our study shows that income status affects the average GCAS total score, and the literature indicates that there is a significant relationship between income status and GCAS scores20. High income levels among women may have facilitated their access to healthcare services due to their high awareness of gynecological cancer. Women with social security coverage were found to have significantly higher mean GCAS total scores. The literature supports this finding24. In this study, having social security may have made it easier for women to communicate with healthcare personnel and increased their awareness.

This study shows that women's age affects the average total BCFS score. A study has indicated that fatalistic attitudes increase with age25. As women age, their fatalistic beliefs about breast cancer increase, suggesting that women associate cancer with age. Our study found that women's fatalism regarding breast cancer decreased as their level of education increased, a finding supported by the literature17. The fact that highly educated women had lower levels of fatalism suggests that they are more aware of breast cancer. This study shows that women with higher incomes have lower breast cancer fatalism scores. Given that income status facilitates individuals’ access to healthcare services, this result obtained from the study is plausible.

According to the regression analysis results, educational status, social security status, prior gynecological examination, and receiving information about gynecological cancers from healthcare personnel explain a low-to-moderate level of variance in gynecological cancer awareness. It can be said that age and education level explain the variance in breast cancer fatalism at a low-to-medium level. The high variance that the models cannot explain suggests that other factors may be effective (cultural beliefs, religious attitudes, health literacy, social support, personal experiences, etc.). Considering that awareness and fatalism are important in the development of positive health behaviors, the results obtained from the study are thought to contribute to the literature and are the expected results. The models show that social security is not significant in terms of fatalism regarding breast cancer. This suggests that, due to women's socio-cultural structure, their sense of privacy is paramount. Furthermore, the perceived ineffectiveness of social security may stem from the collinearity with education. The fatalism scale treats fatalism as a one-dimensional and binary structure for each item. This binary approach may have caused the variance to appear in this way.

CONCLUSION AND RECOMMENDATIONS

In this study, it can be said that both the level of awareness of gynecological cancers and the level of fatalism regarding breast cancer were above average. Educational status, social security status, prior gynecological examination, and receiving information about gynecological cancers from healthcare personnel explain 18.7% of the variance in gynecological cancer awareness. Additionally, age and educational status explain 13.6% of the variance in the BCFS total score average.

Health education programs designed to increase women's awareness levels and reduce fatalism tendencies should be planned, implemented, and maintained by nurses in primary healthcare institutions. Furthermore, studies examining women's gynecological cancer awareness and breast cancer fatalism levels should be planned with a larger sample size.

Limitations

Our study could be conducted with a larger sample size. The results of this study can only be generalized to women aged 30–65 years living in the a family health center area. The study results also show that most of the women are disadvantaged (many are illiterate, lack social security, and are unemployed). Therefore, we cannot generalize the study results to all women. The high rate of illiteracy may have affected the understanding of the data collection tools.

Funding:

none.

DATA AVAILABILITY STATEMENT

The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.

REFERENCES

  • 1 Erenoğlu R, Bayraktar E. Awareness levels of married women aged 20-60 years about gynaecological cancer and the affecting factors. J Caring Sci. 2020;13(1):457-69.
  • 2 Gözüyeşil E, Arıöz A, Taş F. Bir aile sağlığı merkezine başvuran kadınların jinekolojik kanser farkındalıklarının değerlendirilmesi. TJFMPC. 2020;14(2):177-85. https://doi.org/10.21763/tjfmpc.730022
    » https://doi.org/10.21763/tjfmpc.730022
  • 3 World Health Organization (WHO). GLOBOCAN 2022. The Global Cancer Observatory. 2024. [cited on 2026 May 05]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdf
    » https://gco.iarc.who.int/media/globocan/factsheets/cancers/20-breast-fact-sheet.pdf
  • 4 Eker A, Aslan E. Jinekolojik kanser hastalarında psiko-sosyal yaklaşım. Hemşirelikte Eğitim ve Araştırma Dergisi. 2017;14(4):298-303.
  • 5 World Health Organization (WHO). GLOBOCAN 2022 Turkey. 2024. [cited on 2026 Dec 12]. Available from: https://gco.iarc.who.int/media/globocan/factsheets/populations/792-turkiye-fact-sheet.pdf
    » https://gco.iarc.who.int/media/globocan/factsheets/populations/792-turkiye-fact-sheet.pdf
  • 6 Öztürk R, Bakir S, Kazankaya F, Paker S, Ertem G. Awareness about gynecologic cancers and related factors among healthy women: a cross-sectional study. Soc Work Public Health. 2021;36(7-8):847-56. https://doi.org/10.1080/19371918.2021.1965936
    » https://doi.org/10.1080/19371918.2021.1965936
  • 7 Ersin F, Kahraman S, Havlioğlu S. Kadınların jinekolojik kanserler farkındalık durumları ve etkileyen faktörler: Araştırma Makalesi. European Health Sci J. 2024;2(2):28-34. https://doi.org/10.5281/zenodo.13149326
    » https://doi.org/10.5281/zenodo.13149326
  • 8 Atlas B, Güneri SE. Kadınların jinekolojik kanserlerle ilgili farkındalığı ve farkındalığı etkileyen faktörler. İzmir Kâtip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2022;7(1):77-85.
  • 9 Lutalo T, Namusoke F. Health information sources and contraceptive use among women. Int J Public Health. 2023;68:1-9.
  • 10 Ersin F, Capik C, Kissal A, Aydogdu NG, Beser A. Breast cancer fatalism scale: a avalidity and reliability study in Turkey. IJCS. 2018;11(2):783.
  • 11 Ülger E, Alacacıoğlu A, Gülseren AŞ, Zencir G, Demir L, Tarhan MO. Kanserde psikososyal sorunlar ve psikososyal onkolojinin önemi. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi. 2014;28(2):85-92.
  • 12 Ramírez AS. Fatalism and cancer risk knowledge among a sample of highly acculturated Latinas. J Cancer Educ. 2014;29(1):50-5. https://doi.org/10.1007/s13187-013-0541-6
    » https://doi.org/10.1007/s13187-013-0541-6
  • 13 Altintas HK, Ayyildiz TK, Veren F, Topan AK. The effect of breast cancer fatalism on breast cancer awareness among Turkish women. J Relig Health. 2017;56(5):1537-52. https://doi.org/10.1007/s10943-016-0326-4
    » https://doi.org/10.1007/s10943-016-0326-4
  • 14 Vrinten C, Wardle J, Marlow LA. Cancer fear and fatalism among ethnic minority women in the United Kingdom. Br J Cancer. 2016;114(5):597-604. https://doi.org/10.1038/bjc.2016.15
    » https://doi.org/10.1038/bjc.2016.15
  • 15 Aksu B, Ersin F. The effect of breast cancer fatalism and barrier perceptions of female seasonal agricultural workers on their breast cancer early detection behaviors. IJCS. 2023;16(1):386-95.
  • 16 Dal NA, Ertem G. Jinekolojik kanserler farkındalık ölçeği geliştirme çalışması. İnsan ve Toplum Bilimleri Araştırmaları Dergisi. 2017;6(5):2351-67.
  • 17 Powe BD, Hamilton J, Brooks P. Perceptions of cancer fatalism and cancer knowledge: a comparison of older and younger African American women. J Psychosoc Oncol. 2006;24(4):1-13. https://doi.org/10.1300/J077v24n04_01
    » https://doi.org/10.1300/J077v24n04_01
  • 18 Mayo RM, Ureda JR, Parker VG. Importance of fatalism in understanding mammography screening in rural elderly women. J Women Aging. 2001;13(1):57-72. https://doi.org/10.1300/J074v13n01_05
    » https://doi.org/10.1300/J074v13n01_05
  • 19 George D, Mallery P. SPSS for windows: a simple guide and reference 10.0 update. Allyn & Bacon Company; 2001.
  • 20 Çelebi N. Kadınların jinekolojik kanserlere yönelik farkındalıkları ve erken tanı yöntemlerine yönelik davranışlarının değerlendirilmesi. [Yüksek Lisans Tezi, Atatürk Üniversitesi, Sağlık Bilimleri Enstitüsü]. 2021. Available from: https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp
    » https://tez.yok.gov.tr/UlusalTezMerkezi/tezSorguSonucYeni.jsp
  • 21 Tuncer SK, Karakurt P. Kadınların jinekolojik kanserler ile ilgili farkındalık düzeyinin artmasında sağlık okuryazarlığının etkisi üzerine bir araştırma. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi. 2023;13(1):196-206. https://orcid.org/0000-0003-0330-9807
    » https://orcid.org/0000-0003-0330-9807
  • 22 Han B, Baysal HY. Relationship of women's breast cancer fatalism perceptions with health beliefs and early diagnosis behaviors. Adv Women's Stud. 2024;6(2):38-47. https://doi.org/10.51621/aws.1553428
    » https://doi.org/10.51621/aws.1553428
  • 23 Silva AHW, Samarawickrema N, Kasturiratne A, Skinner SR, Wickremasinghe AR, Garland SM. Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: a cross-sectional study. Sex Health. 2019;16(3):212-7. https://doi.org/10.1071/SH18080
    » https://doi.org/10.1071/SH18080
  • 24 Gyamfua AA, Nkrumah I, Ibitoye BM, Agyemang BA, Ofosu ES, Tsoka-Gwegweni JM, et al. The level of knowledge and associated socio-demographic factors on cervical cancer among women: a cross-sectional study at Kenyase Bosore community, Ghana. Pan Afr Med J. 2019;34:44. https://doi.org/10.11604/pamj.2019.34.44.19471
    » https://doi.org/10.11604/pamj.2019.34.44.19471
  • 25 Jamieson PE, Romer D. Unrealistic fatalism in U.S. youth ages 14 to 22: prevalence and characteristics. J Adolesc Health. 2008;42(2):154-60. https://doi.org/10.1016/j.jadohealth.2007.07.010
    » https://doi.org/10.1016/j.jadohealth.2007.07.010

*Corresponding author:

fersin@harran.edu.tr

Conflicts of interest:

the authors declare there is no conflicts of interest.

Scientific Editor:

José Maria Soares Júnior https://orcid.org/0000-0003-0774-9404

Publication Dates

  • Publication in this collection
    28 Sept 2026
  • Date of issue
    2026

History

  • Received
    02 May 2026
  • Accepted
    05 July 2026
location_on
Associação Médica Brasileira R. São Carlos do Pinhal, 324, 01333-903 São Paulo SP - Brazil, Tel: +55 11 3178-6800, Fax: +55 11 3178-6816 - São Paulo - SP - Brazil
E-mail: ramb@amb.org.br
rss_feed Stay informed of issues for this journal through your RSS reader
Go to top Report error